AIM2 and chronic obstructive pulmonary disease: These data are in line with those from other researchers in that inflammasome components, such as caspase-1 and ASC, regardless of the expression of the upstream receptors (Faner et al., 2016), are in their inactive form, suggesting that AIM2 activity could be negatively regulated during the stable status of COPD.